Article
Identification and Validation of Novel Drug Targets in Tuberculosis
1 Oct 2004
Abstract excerpt
There is an urgent need for new antimycobacterial drugs, and in particular for novel agents that will shorten the duration of tuberculosis chemotherapy, or overcome drug-resistant strains of the causative organism, Mycobacterium tuberculosis. Our knowledge of the tubercle bacillus and its complex interaction with the human host has improved dramatically in recent years, particularly with the determination of its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
